Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...
I found community after my metastatic breast cancer diagnosis, but recent discord in cancer support groups makes me fear ...
Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...
Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...
Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at ...
Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death ...
Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...
Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results